IT Versione italiana

video » Specifications of the NGF recombinant human nerve growth factor



related diseases: Neurotrophic Keratitis -

The NGF has proved to be a fundamental component in Neurotrophic Keratitis treatments.  However, it's use, up to a little while ago, was not permitted because it was of animal nature and it could not be commercialised or used in random studies.  Today, thanks to a clinical sperimentation carried out by the Dompè Group, the human recombinant offers new hopes.




Cookies helps us to provide our services. Using these services , you agree to use of cookies on our part. OK